Dashboard

Heska Corp. (HSKA)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

B

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

CEO

Kevin S. Wilson

Employees

386

Industry

Veterinary Products and Services

Sector

Healthcare

Headquarters

Loveland

Exchange

NASDAQ

Summary Stats

Market Cap

1.04B

Revenue

258M

Net Income

-13M

EPS

-$1.28

Price-to-Earnings

-74.99

Price-to-Book

2.42

Debt-to-Equity

0.4

News

Analyst Ratings

Price targets projected by 4 analysts

High

$167.00

Average

$141.00

Low

$95.00

Ratings calculated by 5 analysts

Buy

3

Hold

2

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Not Available

Actual

$0.27 -

Consensus

-

Report Date

Year Ago

0.59

Year Ago Change %

Down 54%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites